Please login to the form below

Not currently logged in
Email:
Password:

Avastin off-licence

This page shows the latest Avastin off-licence news and features for those working in and with pharma, biotech and healthcare.

NHS England sees off AbbVie's Hep C legal challenge

NHS England sees off AbbVie's Hep C legal challenge

But on Friday NHS England announced it had seen off AbbVie’s challenge, issuing a triumphant press release which detailed how the judge had dismissed the case on all counts. ... off-licence in wet age-related macular degeneration.

Latest news

  • Bayer to challenge Avastin legal ruling Bayer to challenge Avastin legal ruling

    England’s use of Avastin is not an isolated one. Health systems in other countries, including France, have also promoted its off-licence use, with a number of publicly-funded trials ... Switching to off-licence Avastin would save £100m or more, if

  • UK doctors call on NHS to use Avastin for wet AMD UK doctors call on NHS to use Avastin for wet AMD

    drug Avastin 'off- licence' to treat wet age-related macular degeneration (AMD). ... Asking Simon Stevens at NHS England to support the case for change and to support clinical commissioners who wish to make local commissioning decisions to prescribe

  • UPDATE: Greater Manchester PCTs react to Avastin off-licence use

    The Association of Greater Manchester PCTs releases a statement following reports in the Guardian yesterday that doctors were prescribing Avastin off-label for wet-AMD to avoid the high costs of ... The association of Greater Manchester PCTs has released

  • NHS may permit off-licence use of Avastin in wet-AMD

    Primary Care Trusts (PCTs) in the Greater Manchester area in the UK have decided to offer patients Avastin off-label on the NHS, while Moorfields eye hospital in London is said ... Some doctors have reported promising results from using Avastin on an

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...

Infographics